Studies on the neuropharmacology of papaverine. 3. The inhibition of ganglionic transmission.
D000109:Acetylcholine / Q000494:pharmacology; D000200:Action Potentials / Q000187:drug effects; D000818:Animals; D001285:Atropine / Q000494:pharmacology; D001338:Autonomic Fibers, Postganglionic / Q000502:physiology; D001794:Blood Pressure / Q000187:drug effects; D002415:Cats; D004305:Dose-Response Relationship, Drug; D005071:Evoked Potentials / Q000187:drug effects; D005260:Female; D005725:Ganglia, Autonomic / Q000187:drug effects*; D006584:Hexamethonium Compounds / Q000494:pharmacology; D008297:Male; D009538:Nicotine / Q000494:pharmacology; D010208:Papaverine / Q000494:pharmacology*; D010646:Phentolamine / Q000494:pharmacology; D010830:Physostigmine / Q000494:pharmacology; D010862:Pilocarpine / Q000494:pharmacology; D000644:Quaternary Ammonium Compounds / Q000494:pharmacology; D011941:Receptors, Adrenergic / Q000187:drug effects; D011950:Receptors, Cholinergic / Q000187:drug effects; D009435:Synaptic Transmission / Q000187:drug effects*; D014403:Tubocurarine / Q000494:pharmacology
D006584:Hexamethonium Compounds; D000644:Quaternary Ammonium Compounds; D011941:Receptors, Adrenergic; D011950:Receptors, Cholinergic; D010862:Pilocarpine; D009538:Nicotine; D001285:Atropine; D010830:Physostigmine; D010208:Papaverine; D000109:Acetylcholine; D014403:Tubocurarine; D010646:Phentolamine